Når primær leverkræft er forbundet med ascites, gulsot, fjernmetastaser osv., kaldes det fremskreden primær leverkræft. Behandlingen af fremskreden primær leverkræft er vanskelig, og den kliniske behandlingseffekt er ikke ideel. Kirurgi er ikke en mulighed for behandling af fremskreden leverkræft, fordi den har spredt sig til lymfeknuder eller andre organer.
If the liver is in good condition (Child-Pugh grade A or B), the doctor will consider treatment with the targeted therapeutic drugs Sorafenib (Nexavar) or Lenvama (Lenvima). Growth can prolong the survival time of patients. If the patient develops drug resistance, the targeted drug repaglinide (Stivarga) or the immunterapi drug nivolumab (Opdivo) can be used instead.
In addition, keeping an eye on clinical trial information at any time and actively participating in relevant clinical trials such as chemotherapy, radiotherapy, and immunotherapy may also bring opportunities and hope for patients with advanced leverkræft. It is hoped that in the next few years, researchers will make a huge breakthrough in the field of liver cancer diagnosis and treatment.
